Medtronic and Eli Lilly join forces to tackle Parkinson's
This article was originally published in Clinica
Executive Summary
Two giants from the pharma and medtech industries, Eli Lilly and Medtronic, are combining their respective know-how in novel biologic compounds and targeted drug delivery technologies to develop a new treatment for Parkinson's disease.